CVS Wins Plaudits for Vowing to Stop Tobacco Sales

Drugstore giant CVS Caremark's decision to stop selling tobacco products at its stores is being hailed as a victory among public health advocates, a move they predict will force CVS competitors to follow suit as they look to play a growing part in the delivery of the country's healthcare.
Published Online: February 06, 2014

Drugstore giant CVS Caremark's decision to stop selling tobacco products at its stores is being hailed as a victory among public health advocates, a move they predict will force CVS competitors to follow suit as they look to play a growing part in the delivery of the country's healthcare.

Major competitors, for the moment though, are not rushing to join CVS in the move away from selling tobacco products.

“This decision underscores our role in the evolving healthcare system,” said CVS spokesman Michael DeAngelis. “Now more than ever, pharmacies are on the front line of healthcare, becoming more involved in chronic disease management to help patients with high blood pressure, high cholesterol and diabetes. All of these conditions are made worse by smoking and cigarettes have no place in a setting where healthcare is delivered.”

Read the full story here: http://bit.ly/1ndkFcA

Source: Modern Healthcare



Feature
Recommended Articles
Clinical pathways (CPs) are increasingly being utilized to improve quality of care and control healthcare costs in the United States. A new report from Avalere Health examines the development of CPs, use of evidence to inform their design, implementation processes, and their impact on quality of care, costs, and outcomes.
Middle-age men especially were more likely to have undiagnosed diabetes if they suffered from erectile dysfunction, according to the study.
Healthcare spending growth between 2014 and 2024 is projected to be substantially lower than the 3 decades prior to 2008, according to a new report from CMS. In addition, the average premium for a basic Medicare Part D prescription plan will remain stable in 2016.
Patient characteristics and product mix play an important role in determining the overall use and costs of comparable insulins across different manufacturers.
Picking the right measurements to assess improvement in medication management depends largely on the what group is being considered, said Woody Eisenberg, MD, senior vice president of performance measurement and strategic alliances for the Pharmacy Quality Alliance.